Allogene Therapeutics, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of ALLO for the last quarter is 0.00 USD, and it's 100.00% lower compared to the previous quarter. The net income of Q2 24 is -66.36 M USD.